The global adrenal fatigue market size is likely to attain over USD 1,137 million by the year 2028. Besides, it is likely to project a CAGR of nearly 7.9% during the forecast years 2021-2028. Deficiency of hormones secreted by the adrenal gland including cortisol and aldosterone due to congenital or acquired disorders is known as adrenal insufficiency. Some of the symptoms of adrenal insufficiency include fatigue, muscle weakness, low appetite, weight loss, and belly pain. Adrenal insufficiency is of three types: Primary, Secondary, and Tertiary.

The present and future adrenal fatigue market progress is summarized to conclude the attractiveness of the entire market. Also, prime factors that influence the adrenal fatigue market opportunities during the forecast years. Factors such as the the increase in awareness regarding timely diagnosis of congenital disorders. Increasing risk of trauma cases due to a number of factors such as road injuries, war-related trauma, other accidents, and increasing global disease burden are the key factors driving the market growth for adrenal fatigue.

Also, demand for development of newer and technologically enhanced products is rising globally, owing to the treatment efficiency of drugs, which is another factor driving market growth. However, poor reimbursement, high cost of treatment, and various side effects associated with drugs are hampering the market growth. Furthermore, the adrenal fatigue market is growing due to technological advancements and increasing R&D activities for the drugs development and rise in number of end-use applications, which are likely to provide lucrative development opportunities for the adrenal fatigue market in the forthcoming years.

The report also emphasizes several distinctiveness of the global adrenal fatigue industry by valuing the market from value chain breakdown. Moreover, the report encompasses numerous qualitative features of the adrenal fatigue industry which comprises market restraints, drivers, as well as key industry opportunities. Furthermore, the report offers an inclusive evaluation of the company profiling along with the market rivalry of local and global vendors.

The adrenal fatigue market has tough competition among the new emerging and pre-established market vendors. Besides, the adrenal fatigue industry vendors are trying to capture the prospective markets to grab a competitive advantage over the remaining industry vendors. To capture the market, market players are forming agreements, acquiring other companies & startups, mergers & acquisitions,  partnerships & collaboration, and escalating their business existence.

Based on the Indication segment, the market is bifurcated into Primary, Secondary and Tertiary. In 2020, secondary segment accumulated the maximum market share and it is likely to continue its dominance throughout the forecast years. It can be caused by an insult or injury to the hypothalamus of the pituitary gland. In this case, the patients require glucocorticoid replacement such as prednisone or hydrocortisone.

The Asia Pacific region is likely to account for the maximum market contribution during the forecast years. The domination of this region is largely ascribed to the improving health care infrastructure, rising awareness about timely diagnosis of underlying disorders such as adrenal insufficiency, and large patient population. Increase in public and private health care expenditure in countries such as China and India is expected to attract manufacturers toward these markets.

The major players of the global adrenal fatigue market are The major players of the global adrenal fatigue market are Pfizer, Inc., Mylan Pharmaceuticals, Inc., Novartis International AG, Mallinckrodt Pharmaceuticals, Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company and Sanofi. Renowned companies are offering new and modern forms of adrenal fatigue which can be either in liquid or powdered state. Besides, the previously recognized as well as new market players are approaching the market with advanced and new strategic services and solutions and to remain competitive in the global market.

Segment Overview of Global Adrenal Fatigue Market

Indication Overview, 2019-2028 (USD Million)

• Primary
• Secondary
• Tertiary

Source Overview, 2019-2028 (USD Million)

• Congenital
• Acquired

Treatment Overview, 2019-2028 (USD Million)

• Glucocorticoids
• Corticotropin
• Others

Distribution Channel Overview, 2019-2028 (USD Million)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Overview, 2019-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Middle East and Africa
  • UAE
  • South Africa
  • Rest of Middle East and Africa

• South America
  • Brazil
  • Rest of South America